A Preclinical Assessment of 89Zr-atezolizumab Identifies a Requirement for Carrier Added Formulations Not Observed with 89Zr-C4

作者:Anna, Moroz; Chia-Yin, Lee; Yung-hua, Wang; Jeffrey C., Hsiao; Natalia, Sevillano; Charles, Truillet; Charles S., Craik; Lawrence, Fong; Cheng-I, Wang; Michael J., Evans
来源:Bioconjugate Chemistry, 2018, 29(10): 3476-3482.
DOI:10.1021/acs.bioconjchem.8b00632
  • 出版日期2018-10-17
  • 单位中国地震局